The global isoflavones market size is expected to reach $ 1. 4 billion by 2027, increasing to a market growth of 6.4% CAGR during the forecast period. Isoflavones refer to polyphenolic compounds that exhibit characteristics of estrogen antagonists and agonists.
New York, October 26, 2021 (GLOBE NEWSWIRE) – Reportlinker.com announces the publication of the report “Global Isoflavones Market By Form, By Application, By Source, By Regional Outlook, Industry Analysis Report and Forecast, 2021-2027” – https://www.reportlinker.com/p06177769/?utm_source=GNW
Glycine, genistein and daidzein are the most active isoflavones available in soybeans and they are also the phytoestrogens with strong estrogenic activity. Various clinical studies have shown that genistein and daidzein are extremely useful in preventing prostate and breast cancer, osteoporosis, and cardiovascular disease and in relieving postmenopausal symptoms.
The isoflavones market is reportedly experiencing lucrative growth opportunities due to the awareness of the health benefits of isoflavones as well as the growing geriatric population. In addition, the global market is expected to be fueled by the growing number of working women and increased purchasing power of consumers for healthy food products.
In addition, the market growth would be increased by the increasing demand for nutraceutical supplements in all age groups as well as by the increase in disposable income of the world population. Geriatrics has been the global trend in both established and emerging countries. All over the world, consumers are concerned about changes in their quality of life and are closely monitoring their eating habits. The consumption of infant formula containing flavonoids has been fueled due to the increasing number of working mothers around the world, thus increasing the demand and growth of isoflavones in the market.
Impact of COVID-19
The outbreak of the COVID-19 pandemic has had a significant impact on the isoflavone market. Isoflavones find many applications in a variety of products such as nutraceuticals, dietary supplements, and pharmaceuticals. Isoflavone products are beneficial in improving muscle mass and immunity. Due to this aspect, the demand for isoflavone products has increased over the past two years.
The demand for isoflavones among consumers has been fueled due to the increase in health concerns and increased consumer awareness, which has resulted in a huge demand for fortified foods. Besides the available medical health supplements, consumers are very inclined towards isoflavone based dietary supplements because they are made from plants. Consumers’ awareness regarding the consumption of healthy diets and supplements has been heightened due to the outbreak of the COVID-19 pandemic. Most dietary supplements and nutraceuticals contain isoflavones which are helpful in improving gut health. Therefore, the outbreak of the COVID-19 pandemic has significantly affected the growth of the isoflavones market.
Market growth factors:
Market is expected to boost due to high frequency of menopause issues
Women going through menopause face different types of issues like insomnia, hot flashes, and in many cases, sexual dysfunction. Most women tend to buy supplements that contain estrogen which could dramatically increase the risk of blood clots, breast cancer, stroke, or uterine cancer. Therefore, estrogen is not the feasible choice for most women due to their health and family history.
The advent of the latest technologies
One of the new improvements in drug development is the use of nanotechnology for API synthesis. The advent of nanoparticle technologies for API delivery is indeed showing its great potential as an innovative and efficient approach. Nanobodies are the same as single domain antibodies which can be attached to particular antigens; however, they are smaller compared to antibodies.
Market restriction factor:
Isoflavones are less effective than their counterparts
Soy isoflavones can take several weeks or more to reach their benefits in the market. For example, according to Healthline Media (US), a 2015 study found that soy isoflavones take more than 13 weeks to reach only half of their highest effect. Conventional hormones like estrogen therapy; however, it takes about three weeks to display the same types of benefits.
On the basis of form, the market is segmented into powder and liquid. The powder segment has provided the maximum revenue share of the global isoflavones market in 2020. This is due to the prevailing trends in the isoflavones market such as easy handling and use of isoflavones in various nutraceutical and pharmaceutical applications. .
On the basis of application, the market is segmented into pharmaceuticals, nutraceuticals, cosmetics, and food and beverage. The pharmaceutical segment would acquire the maximum share of revenue throughout the forecast period. This is due to the increasing use of isoflavones due to their therapeutic and functional properties.
On the basis of source, the market is segmented into red clover, soybeans, and other sources. Isoflavones are extracted from peas, soybeans, red clover, and other natural sources. Soybean extracts achieved the highest revenue share in the global market in 2020. Moreover, the segment is expected to show a similar trend during the forecast period. Other sources like lentils, red clover, peas, beans, green tea, and flaxseeds have gained moderate revenue share of the global isoflavones market in 2020. Numerous research organizations performing the process Extractors strive to create the most recent and advanced methods to extract isoflavones from their sources.
On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific and Latin America, Middle East and Africa. Asia-Pacific is one of the major regions in the global isoflavone market. Some of the main countries in the region are India, China, Japan and South Korea, which are also the biggest consumers of soy and its products in the world. As a result, the demand for isoflavones is not very high in these countries. The demand for the product in Asian economies is much lower compared to Western countries due to the high consumption of beans, soybeans, peas and other sources in their daily diet. In addition, a significant part of the population suffers from breast cancer and other diseases, thus increasing the demand for isoflavones in the regional market.
The market research report covers the analysis of the major players in the market. Key companies featured in the report include Archer Daniels Midland Company, BASF SE, Koninklijke DSM NV, International Flavors & Fragrances, Inc. (DuPont Nutrition), Shanghai Freemen, LLC, Nexira, Inc., Hyundai Bioland, Tradichem SL, FutureCeuticals, Inc. (RJ Van Drunen & Sons, Inc.) and Lactonova Nutripharm Pvt. Ltd.
Strategies deployed on the isoflavones market
August 2020: BASF unveiled Xitavo-branded soybean with Enlist E3 technology in the United States. This new seed would help soybean growers have more choice and flexibility in choosing herbicide tolerance traits, genetics, BASF seed treatments and crop protection solutions.
February 2020: ADM expanded production of its existing product, viz. non-GMO soy protein concentrate at its Europoort plant in the Netherlands. This manufacturing unit manufactured a non-GMO soy protein concentrate, available in powder form and suitable for any type of food application.
Sept-2019: Frutarom Health, a division of International Flavors & Fragrances, launched a new line of Organic SoyLife Complex soy isoflavones. The product is made using non-GMO organic soybeans grown for conventional food production.
December 2018: BASF introduced Obvius Plus fungicidal seed treatment and Vault IP Plus seed treatment. With this launch, the company has expanded its portfolio of soybean seed treatments and offers soybean growers a wider product offering.
Aug-2018: BASF deployed Credenz soybean with LibertyLink GT27, the first soybean seed technology of its kind with herbicide-tolerant stacked traits. The technology would help growers apply both Liberty herbicide and glyphosate to the top of soybeans for post-emergence control of broadleaf and grass weeds.
Feb-2018: Archer Daniels Midland has formed a joint venture with Cargill named SoyVen. This joint venture aimed to offer soybean flour and oil to Egyptian customers.
Jan-2018: ADM expanded its geographic reach by establishing an innovation center in Singapore. The new facility would promote the development of ingredients and the application of food, industrial, food and energy products.
Scope of the study
Market segments covered in the report:
• Pharmaceutical products
• Food and drinks
• Red clover
• Other sources
• North America
o United States
o Rest of North America
o Rest of Europe
• Asia Pacific
o South Korea
o Rest of Asia-Pacific
o United Arab Emirates
o Saudi Arabia
o Rest of LAMEA
• Archer Daniels Midland Company
• BASF SE
• Koninklijke DSM NV
• International Flavors & Fragrances, Inc. (DuPont Nutrition)
• Shanghai Freemen, LLC
• Nexira, Inc.
• Hyundai Bioland
• Tradichem SL
• FutureCeuticals, Inc. (RJ Van Drunen & Sons, Inc.)
• Lactonova Nutripharm Pvt. Ltd.
• Comprehensive coverage
• The largest number of tables and figures on the market
• Subscription-based model available
• Best price guaranteed
• After-sales research support guaranteed with 10% free customization
Read the full report: https://www.reportlinker.com/p06177769/?utm_source=GNW
On Report link
ReportLinker is an award winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001